Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedDec 04, 2023
DataAggregated Company Financials
Companies29
  • 7D-2.1%
  • 3M-12.5%
  • 1Y-17.4%
  • YTD-16.2%

Over the last 7 days, the Biotech industry has dropped 2.1%, driven by Noile-Immune Biotech declining 20%. In contrast, PeptiDream has gained 6.7%. Overall the industry is down 17% in 12 months. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 04 Dec 2023JP¥788.4bJP¥221.9b-JP¥12,426,487,000.0016.9x-63.4x3.6x
Wed, 01 Nov 2023JP¥723.9bJP¥223.0b-JP¥14,478,735,000.0017.8x-50x3.2x
Fri, 29 Sep 2023JP¥851.2bJP¥223.0b-JP¥14,518,735,000.0026.6x-58.6x3.8x
Sun, 27 Aug 2023JP¥896.5bJP¥225.1b-JP¥19,814,131,000.0047.6x-45.2x4x
Tue, 25 Jul 2023JP¥918.7bJP¥223.7b-JP¥20,836,669,000.0047x-44.1x4.1x
Thu, 22 Jun 2023JP¥996.9bJP¥223.2b-JP¥20,139,670,000.0062.1x-49.5x4.5x
Sat, 20 May 2023JP¥915.5bJP¥218.8b-JP¥25,249,938,000.0032.1x-36.3x4.2x
Mon, 17 Apr 2023JP¥953.7bJP¥218.3b-JP¥21,583,522,000.0021.9x-44.2x4.4x
Wed, 15 Mar 2023JP¥897.5bJP¥218.1b-JP¥18,469,580,000.0020.5x-48.6x4.1x
Fri, 10 Feb 2023JP¥973.0bJP¥186.7b-JP¥24,854,541,000.0039.5x-39.1x5.2x
Sun, 08 Jan 2023JP¥907.3bJP¥186.8b-JP¥24,722,604,000.0041.8x-36.7x4.9x
Tue, 06 Dec 2022JP¥900.6bJP¥182.1b-JP¥23,615,433,000.0046x-38.1x4.9x
Thu, 03 Nov 2022JP¥826.9bJP¥176.5b-JP¥24,989,270,000.0048.5x-33.1x4.7x
Sat, 01 Oct 2022JP¥852.9bJP¥176.5b-JP¥24,974,270,000.0042.3x-34.2x4.8x
Mon, 29 Aug 2022JP¥975.2bJP¥174.4b-JP¥21,144,270,000.0022.8x-46.1x5.6x
Wed, 27 Jul 2022JP¥960.3bJP¥171.3b-JP¥16,112,943,000.0020.4x-59.6x5.6x
Fri, 24 Jun 2022JP¥847.1bJP¥171.3b-JP¥16,112,832,000.0019.4x-52.6x4.9x
Sun, 22 May 2022JP¥926.1bJP¥169.1b-JP¥13,290,328,000.0011.6x-69.7x5.5x
Tue, 19 Apr 2022JP¥1.0tJP¥164.2b-JP¥13,043,295,000.0014.6x-80x6.4x
Thu, 17 Mar 2022JP¥1.0tJP¥164.2b-JP¥13,044,654,000.0014.7x-77.4x6.1x
Sat, 12 Feb 2022JP¥1.0tJP¥157.7b-JP¥7,205,039,000.0016x-144.5x6.6x
Mon, 10 Jan 2022JP¥1.2tJP¥163.5b-JP¥5,447,358,000.0018x-214.3x7.1x
Wed, 08 Dec 2021JP¥1.2tJP¥159.5b-JP¥8,763,358,000.0018.3x-137.6x7.6x
Fri, 05 Nov 2021JP¥1.4tJP¥147.6b-JP¥12,310,127,000.0024.6x-112.2x9.4x
Sun, 03 Oct 2021JP¥1.6tJP¥147.6b-JP¥12,269,440,000.0025x-128.7x10.7x
Tue, 31 Aug 2021JP¥1.7tJP¥148.3b-JP¥14,096,440,000.0025.3x-118.2x11.2x
Wed, 07 Jul 2021JP¥1.9tJP¥139.5b-JP¥15,500,440,000.0033.2x-122.9x13.7x
Sat, 10 Apr 2021JP¥1.9tJP¥122.0b-JP¥18,475,632,000.0061.1x-102.2x15.5x
Fri, 01 Jan 2021JP¥1.8tJP¥103.8b-JP¥25,953,087,000.00125.6x-68.8x17.2x
Price to Earnings Ratio

-69.9x


Total Market Cap: JP¥1.9tTotal Earnings: -JP¥27,284,135,000.00Total Revenue: JP¥90.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -80x202120222023
Current Industry PE
  • Investors are pessimistic on the Japanese Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.7x is higher than the industry's current PS ratio of 3.6x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have improved over the last three years.
  • Revenues for these companies have grown 35% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-0.35%
Healthcare0.19%
Biotech-2.14%
Biotech-2.14%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4587 PeptiDreamJP¥1.28k6.7%
+JP¥10.4b
-21.3%PE14.7x
2160 GNI GroupJP¥3.22k5.1%
+JP¥7.4b
123.6%PE100.2x
4597 Solasia Pharma K.KJP¥53.0029.3%
+JP¥2.0b
-1.9%PS7.4x
4575 CanBasJP¥1.06k4.4%
+JP¥797.5m
-6.6%PB6.3x
4593 Healios K.KJP¥185.004.5%
+JP¥596.3m
-38.1%PS79.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4974

JP¥1,199.00

Takara Bio

7D

-1.2%

1Y

-31.5%

4882

JP¥713.00

Perseus Proteomics

7D

-8.4%

1Y

106.1%

4893

JP¥315.00

Noile-Immune Biotech

7D

-20.1%

1Y

n/a

2929

JP¥1,270.00

Pharma Foods International

7D

-2.9%

1Y

-1.9%

2160

JP¥3,215.00

GNI Group

7D

5.1%

1Y

123.6%

4593

JP¥185.00

Healios K.K

7D

4.5%

1Y

-38.1%

4597

JP¥53.00

Solasia Pharma K.K

7D

29.3%

1Y

-1.9%

4588

JP¥607.00

Oncolys BioPharma

7D

3.8%

1Y

19.0%

7777

JP¥171.00

3-D Matrix

7D

3.0%

1Y

-43.8%

4564

JP¥23.00

OncoTherapy Science

7D

-11.5%

1Y

-61.0%

4587

JP¥1,282.50

PeptiDream

7D

6.7%

1Y

-21.3%

4599

JP¥674.00

StemRIM

7D

-2.0%

1Y

-27.8%

4894

JP¥1,831.00

Cuorips

7D

3.4%

1Y

n/a

4598

JP¥911.00

Delta-Fly Pharma

7D

-13.0%

1Y

5.3%

4575

JP¥1,059.00

CanBas

7D

4.4%

1Y

-6.6%

4571

JP¥217.00

NANO MRNALtd

7D

-7.7%

1Y

13.6%